Anti-Irritants Agents for the Treatment of Irritant Contact Dermatitis: Clinical and Patent Perspective

Author(s): Hongbo Zhai, Howard I. Maibach

Journal Name: Recent Patents on Inflammation & Allergy Drug Discovery
Continued as Recent Advances in Inflammation & Allergy Drug Discovery

Volume 6 , Issue 3 , 2012


This overview defines whether anti-irritant agents, in fact, inhibit, prevent or treat irritant contact dermatitis (ICD) in man. We performed a literature search using PubMed, EMBASE, and Scopus via the library at University of California San Francisco, and a hand search of relevant text books to investigate chemicals that can be considered antiirritants in either prevention or treatment. Emphasis was placed on data that included quantitative and qualitative results and that followed evidence-based dermatological guidelines. Related patents were summarized. Conflicting observations summarized here suggest well controlled, but often arduous, field type studies are required for confirmation.

Keywords: Barrier cream (BC), bioengineering, irritant contact dermatitis (ICD), moisturizers, occupational, prevention, treatment, occupational dermatitis, Anti-irritants agents, Natural Anti-Irritant, Nonsteroidal Anti-Inflammatory Agents, Phosphodiesterase Inhibitors, Corticosteroids.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 06 August, 2012
Page: [169 - 185]
Pages: 17
DOI: 10.2174/187221312802652857
Price: $65

Article Metrics

PDF: 12